Stanford Downgrades First Solar (FSLR) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts FSLR Hot Sheet
Price: $179.72 +1.07%
Rating Summary:
39 Buy, 17 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
39 Buy, 17 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
Stanford Group downgrades First Solar (Nasdaq: FSLR) from Hold to Sell.
Investors are selling shares of First Solar on the downgrade today. Additionally, traders may also still be responding to reduced guidance at Q-Cells yesterday. Q-Cells is the largest maker of solar cells, and so the news was negative for the entire solar sector, including First Solar, which was down about 12% at yesterday's close.
First Solar is currently down about 0.5% to $116.70.
First Solar, Inc. designs, manufactures, and sells solar electric power modules using a proprietary thin film semiconductor technology.
Investors are selling shares of First Solar on the downgrade today. Additionally, traders may also still be responding to reduced guidance at Q-Cells yesterday. Q-Cells is the largest maker of solar cells, and so the news was negative for the entire solar sector, including First Solar, which was down about 12% at yesterday's close.
First Solar is currently down about 0.5% to $116.70.
First Solar, Inc. designs, manufactures, and sells solar electric power modules using a proprietary thin film semiconductor technology.
You May Also Be Interested In
- Truist Securities Upgrades First Solar (FSLR) to Buy
- Deutsche Bank Downgrades C.H. Robinson Worldwide (CHRW) to Hold
- Wolfe Research Downgrades Insmed (INSM) to Peerperform
Create E-mail Alert Related Categories
Downgrades, Insiders' BlogRelated Entities
StanfordSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
